Stewart & Patten CO LLC Bristol Myers Squibb CO Transaction History

Stewart & Patten CO LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $190,034 - $227,868	3,091 New	3,091 $226,000
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $206,562 - $241,961	-3,491 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 2.78%	3,491 $233,000
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $32,892 - $38,454	-600 Reduced 14.32%	3,591 $211,000
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $255,200 - $370,865	-5,500 Reduced 56.75%	4,191 $234,000
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $496,725 - $647,933	-10,094 Reduced 51.02%	9,691 $622,000
Q3 2019 Oct 17, 2019	BUY	$42.77 - $50.71 $2,480 - $2,941	58 Added 0.29%	19,785 $1 Million
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $6,603 - $7,302	-148 Reduced 0.74%	19,727 $895,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $2,346 - $2,797	-52 Reduced 0.26%	19,875 $948,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $31,645 - $41,036	-649 Reduced 3.15%	19,927 $1.04 Million
Q3 2018 Oct 22, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 0.96%	20,576 $1.28 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $30,267 - $37,725	-599 Reduced 2.8%	20,776 $1.15 Million
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $35,592 - $40,974	594 Added 2.86%	21,375 $1.35 Million
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $1.15 Million - $1.32 Million	20,781	20,781 $1.32 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

Stay updated on Stewart & Patten CO LLC with notifications on news.